Most notably, in glioma, FKBP51 exhibits a unique context-dependent duality, potentially suppressing tumor growth via AKT inhibition while simultaneously promoting immune escape through regulation of PD-L1 expression. This evidence concerns the gene FKBP5 and central nervous system cancer.